Precision Therapeutics will proudly continue its dedicated support to the NOCC Pittsburgh Chapter's 13th Annual Walk to Break the Silence on Ovarian Cancer. Precision has been a strong supporter of the NOCC 5 Mile Run/5 Mile & 1 Mile walk for over five years, and once again expects a great number of its employees will join together in full force to walk alongside ovarian cancer patients and survivors to help strengthen the partnerships it has forged by supporting the very cancer patients that it strives to help.
“We're honored to be part of this event, which supports the promotion of ovarian cancer awareness.”
As part of its sponsorship, Precision will reward every employee participating in the race with a pre-paid registration.
"As we build on our success in personalized cancer treatment and look to the entire continuum of cancer care, the NOCC Walk to Break the Silence is one of the most prestigious fundraisers with which we could be affiliated," said Sean McDonald, President and CEO of Precision Therapeutics. "We're honored to be part of this event, which supports the promotion of ovarian cancer awareness."
The NOCC Walk to Break the Silence will take place on Sunday, September 8, 2013 at the North Park Boathouse in Pittsburgh. For more information on the National Ovarian Cancer Coalition, please visit www.ovarian.org.
Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies